Trexquant Investment’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-62,679
| Closed | -$3.2M | – | 1597 |
|
|
2024
Q3 | $3.2M | Buy |
62,679
+40,141
| +178% | +$2.05M | 0.04% | 644 |
|
|
2024
Q2 | $1.01M | Buy |
+22,538
| New | +$1.01M | 0.02% | 998 |
|
|
2024
Q1 | – | Sell |
-22,644
| Closed | -$806K | – | 1479 |
|
|
2023
Q4 | $806K | Buy |
22,644
+15,233
| +206% | +$542K | 0.02% | 900 |
|
|
2023
Q3 | $220K | Buy |
+7,411
| New | +$220K | 0.01% | 1316 |
|
|
2023
Q2 | – | Sell |
-12,703
| Closed | -$204K | – | 1497 |
|
|
2023
Q1 | $204K | Buy |
+12,703
| New | +$204K | 0.01% | 1314 |
|
|
2022
Q4 | – | Sell |
-24,509
| Closed | -$481K | – | 1421 |
|
|
2022
Q3 | $481K | Buy |
24,509
+10,493
| +75% | +$206K | 0.02% | 828 |
|
|
2022
Q2 | $261K | Buy |
+14,016
| New | +$261K | 0.01% | 1197 |
|